Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
Research & Development
Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.
How We Discover
From initial discovery to a marketable medicine is a long, challenging road. It takes about 12 - 15 years from discovery to the approved medication and requires an investment of about US $1 billion.
Working at Boehringer Ingelheim – Being part of a global family
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
New company video of Boehringer Ingelheim – Value through Innovation
28 Nov 2016 at 14:00
Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss
@BOEHRINGER 11 Oct 2016 at 11:36
Making More Health
For new and better ways of improving health around the globe!
New Member of the Board of Managing Directors of Boehringer Ingelheim/ Responsible for Corporate Board Division Finance
Partnerships are important in creating innovation. Read more about Dr Paola Casarosa and her work on developing therapeutic alliances and strategic partnerships.